Literature DB >> 28515281

CXCL4 Exposure Potentiates TLR-Driven Polarization of Human Monocyte-Derived Dendritic Cells and Increases Stimulation of T Cells.

Sandra C Silva-Cardoso1,2, Alsya J Affandi1,2, Lotte Spel1,3, Marta Cossu1,2, Joel A G van Roon1,2, Marianne Boes4,3, Timothy R D J Radstake4,2.   

Abstract

Chemokines have been shown to play immune-modulatory functions unrelated to steering cell migration. CXCL4 is a chemokine abundantly produced by activated platelets and immune cells. Increased levels of circulating CXCL4 are associated with immune-mediated conditions, including systemic sclerosis. Considering the central role of dendritic cells (DCs) in immune activation, in this article we addressed the effect of CXCL4 on the phenotype and function of monocyte-derived DCs (moDCs). To this end, we compared innate and adaptive immune responses of moDCs with those that were differentiated in the presence of CXCL4. Already prior to TLR- or Ag-specific stimulation, CXCL4-moDCs displayed a more matured phenotype. We found that CXCL4 exposure can sensitize moDCs for TLR-ligand responsiveness, as illustrated by a dramatic upregulation of CD83, CD86, and MHC class I in response to TLR3 and TLR7/8-agonists. Also, we observed a markedly increased secretion of IL-12 and TNF-α by CXCL4-moDCs exclusively upon stimulation with polyinosinic-polycytidylic acid, R848, and CL075 ligands. Next, we analyzed the effect of CXCL4 in modulating DC-mediated T cell activation. CXCL4-moDCs strongly potentiated proliferation of autologous CD4+ T cells and CD8+ T cells and production of IFN-γ and IL-4, in an Ag-independent manner. Although the internalization of Ag was comparable to that of moDCs, Ag processing by CXCL4-moDCs was impaired. Yet, these cells were more potent at stimulating Ag-specific CD8+ T cell responses. Together our data support that increased levels of circulating CXCL4 may contribute to immune dysregulation through the modulation of DC differentiation.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28515281     DOI: 10.4049/jimmunol.1602020

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  An Insight into Recent Advances on Platelet Function in Health and Disease.

Authors:  Preeti Kumari Chaudhary; Sanggu Kim; Soochong Kim
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

Review 2.  Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy.

Authors:  Thiago A Patente; Mariana P Pinho; Aline A Oliveira; Gabriela C M Evangelista; Patrícia C Bergami-Santos; José A M Barbuto
Journal:  Front Immunol       Date:  2019-01-21       Impact factor: 7.561

3.  Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.

Authors:  A Ottria; A T Hoekstra; M Zimmermann; M van der Kroef; N Vazirpanah; M Cossu; E Chouri; M Rossato; L Beretta; R G Tieland; C G K Wichers; E Stigter; C Gulersonmez; F Bonte-Mineur; C R Berkers; T R D J Radstake; W Marut
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

4.  CXCL4 suppresses tolerogenic immune signature of monocyte-derived dendritic cells.

Authors:  Sandra C Silva-Cardoso; Weiyang Tao; Beatriz Malvar Fernández; Marianne Boes; Timothy R D J Radstake; Aridaman Pandit
Journal:  Eur J Immunol       Date:  2020-07-10       Impact factor: 5.532

5.  Monocytes complexed to platelets differentiate into functionally deficient dendritic cells.

Authors:  Meera V Singh; Sumanun Suwunnakorn; Sydney R Simpson; Emily A Weber; Vir B Singh; Pawel Kalinski; Sanjay B Maggirwar
Journal:  J Leukoc Biol       Date:  2020-07-14       Impact factor: 4.962

6.  Inhibition of Dendritic Cell Activation and Modulation of T Cell Polarization by the Platelet Secretome.

Authors:  Anno Saris; Juulke Steuten; David P Schrijver; Gijs van Schijndel; Jaap Jan Zwaginga; S Marieke van Ham; Anja Ten Brinke
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  CXCL4 is a novel inducer of human Th17 cells and correlates with IL-17 and IL-22 in psoriatic arthritis.

Authors:  Alsya J Affandi; Sandra C Silva-Cardoso; Samuel Garcia; Emmerik F A Leijten; Tessa S van Kempen; Wioleta Marut; Joel A G van Roon; Timothy R D J Radstake
Journal:  Eur J Immunol       Date:  2018-01-15       Impact factor: 5.532

Review 8.  Novel insights into dendritic cells in the pathogenesis of systemic sclerosis.

Authors:  T Carvalheiro; M Zimmermann; T R D J Radstake; W Marut
Journal:  Clin Exp Immunol       Date:  2020-02-13       Impact factor: 4.330

9.  The Probiotic BB12 Induces MicroRNAs Involved in Antigen Processing and Presentation in Porcine Monocyte-Derived Dendritic Cells.

Authors:  Marlene Bravo-Parra; Marina Arenas-Padilla; Valeria Brcenas-Preciado; Jesús Hernández; Verónica Mata-Haro
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

10.  CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro.

Authors:  Sandra C Silva-Cardoso; Weiyang Tao; Chiara Angiolilli; Ana P Lopes; Cornelis P J Bekker; Abhinandan Devaprasad; Barbara Giovannone; Jaap van Laar; Marta Cossu; Wioleta Marut; Erik Hack; Rob J de Boer; Marianne Boes; Timothy R D J Radstake; Aridaman Pandit
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.